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Evidence suggests that contemporary population distributions of estrogen-receptor (ER) status among breast cancer patients may be shaped by earlier major societal events, such as the 1965 abolition of legal racial discrimination in the United States (state and local "Jim Crow" laws) and the Great Famine in China (1959) (1960) (1961) . We analyzed changes in ER status in relation to Jim Crow birthplace among the 46,417 black and 339,830 white US-born, nonHispanic women in the Surveillance, Epidemiology, and End Results (SEER) 13 Registry Group who were born between 1915 and 1979 and diagnosed (ages 25-84 years, inclusive) during 1992-2012. We grouped the cases according to birth cohort and quantified the rate of change using the haldane (which scales change in relation to biological generation). The percentage of ER-positive cases rose according to birth cohort (1915-1919 to 1975-1979 ) only among women diagnosed before age 55. Changes according to biological generation were greater among black women than among white women, and among black women, they were greatest among those born in Jim Crow (versus non-Jim Crow) states, with this group being the only group to exhibit high haldane values (>|0.3|, indicating high rate of change). Our study's analytical approach and findings underscore the need to consider history and societal context when analyzing ER status among breast cancer patients and racial/ethnic inequities in its distribution. black; breast cancer; estrogen receptor; generation; haldane; Jim Crow; racial segregation; secular trend Abbreviations: CI, confidence interval; ER, estrogen receptor; ER+, estrogen receptor-positive; ER−, estrogen receptor-negative; NCI, National Cancer Institute; OR, odds ratio; SEER, Surveillance, Epidemiology, and End Results.
Evidence indicates that expression of the estrogen receptor (ER), a key biomarker that is predictive of prognosis in breast cancer, is regulated by methylation and is modifiable (1) (2) (3) (4) (5) (6) . However, while the clinical significance of the temporal dynamics of breast tumor ER expression has gained attention (7, 8) , research on long-term population trends in ER status of breast cancer tumors remains limited (9) .
The pace of change of phenotypic characteristics across generations can provide important insight into the extent to which their expression is driven by factors external to organisms and their inherited genomes (10) (11) (12) (13) (14) . In evolutionary biology, one useful metric for quantifying this pace of change is the haldane, a "calculation of rates in phenotypic standard deviation per generation" (10, p. 453), which can be meaningfully compared within and across species, regardless of their lifespan (10) (11) (12) (13) (14) (15) .
To date, use of the haldane to analyze contemporary rates of microevolution has focused chiefly on diverse animal species (e.g., to study the biological impact of ecosystem change induced by human activity) (10) (11) (12) (13) (14) . By contrast, only a handful of studies have employed the haldane to quantify the pace of change in contemporary human phenotypic traits (15) (16) (17) (18) , and none have applied it to analysis of cancer.
Our study took the novel step of scaling the rate of change in the prevalence of breast cancer ER status according to biological generation, as tied also to the timing of major societal changes. We specifically focus on US black and white women relative to the place and year of their birth, as framed by the system of Jim Crow laws in the United States (i.e., state and local legal racial discrimination); Jim Crow laws were abolished in 1965 (19) (20) (21) (22) . At issue is whether the racism imposed by Jim Crow laws affected health above and beyond the racism experienced in states that did not have Jim Crow laws, thereby shaping trends in both the health of black Americans and the magnitude of black versus white health inequities (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) .
Motivating our research were both: 1) persistent unresolved questions about social versus genetic causes of the US black versus white excess of ER-negative (ER−) tumors, especially at younger ages (9, (30) (31) (32) (33) (34) ; and 2) empirical evidence regarding the historical contingency of the population distribution of, and social inequalities in, breast cancer ER status (9, 35, 36) . Thus, despite enormous heterogeneity in breast cancer ER status among diverse African nations (37) , some researchers refer to "African" breast cancer and focus on genetic causes of black versus white disparities in ER− breast cancer (31, 34) , whereas others call attention to likely social drivers of racial/ethnic disparities in breast cancer ER status and their potential malleability (30, 32, 33) . Suggestively, the US black versus white ER− excess risk rose during the 1990s but then fell (35) following the 2002 publication of Women's Health Initiative results showing that hormone therapy increased the risk of breast cancer without conferring protection for cardiovascular disease, leading to its declining use among women with access to this medication (38, 39) .
Two new studies have also suggested that breast cancer ER status among contemporary cases (1990s-2010s) may be shaped by major societal events that occurred decades earlier (36, 40) . These studies found ER status to be associated with: 1) in the US, exposure to birthplace with Jim Crow laws among US black women (but not white women) born before 1965 (i.e., born in a state with versus without legal racial discrimination prior to passage of the US Civil Rights Act of 1964) (36); and 2) in China, exposure to the Great Famine of 1959-1961 (40) . Biological pathways that could potentially link these social changes to breast cancer ER status include social adversity starting in early life, affecting nutrition, body build, and reproductive history (including age at menarche, age at first birth, parity, and breastfeeding), as well as later life access to screening and to hormone therapy (36, (40) (41) (42) (43) (44) (45) (46) (47) (48) .
METHODS

Data source
Our custom data set (36) , provided by the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) program, comprised women in the SEER 13 Registry Group (excluding Alaska) (49, 50) who were diagnosed with primary invasive breast cancer between January 1, 1992 (when this group was established), and December 31, 2012. The SEER data set included 47,157 US-born, black non-Hispanic women and 348,514 US-born, white non-Hispanic women who were aged 25-84 years, inclusive, at time of diagnosis, and we refer to these groups hereafter as "black" and "white." Because of the small number of women observed who were born either before 1915 (black: 1.2%; white: 2.4%) or after 1979 (black: 0.3%; white: 0.1%), we limited the analytical data set to the 46,417 black women and 339,830 white women born between 1915 and 1979.
Cancer registry data, obtained from hospital medical records, pertained to the cases' breast cancer ER status, year of diagnosis, age at diagnosis, tumor characteristics (size, stage, histology, and grade), and vital status. The NCI added to each case record 2 additional variables: The first was birthplace, categorized as "Jim Crow" versus "non-Jim Crow," based on data we provided to the NCI about states' pre-1965 Jim Crowlaws status (19, 36) ; confidentiality policies precluded the NCI from releasing the specific state of birth. The second was the quintile ranking for the SEER socioeconomic index for each case's residential census tract at time of diagnosis, based on the index's annual national distribution for that year (51, 52) . Use of census tract socioeconomic measures, including for cancer registries, has been validated in prior research (51) (52) (53) (54) .
This work was designated by the institutional review board as exempt (Harvard School of Public Health IRB protocol #IRB13-1796).
Statistical analysis
To address well-known problems regarding missing birthplace data in cancer registry records (because birthplace data are obtained primarily from death certificate data (55) (56) (57) ) and missing ER data (30, 58, 59) , we used SAS (SAS Institute, Inc., Cary, North Carolina) PROC MI with fully conditional specification (60) to create 10 multiply imputed data sets, under the missing-at-random (MAR) assumption that the missingdata mechanism involved solely the observed data (60, 61) . Variables included in the imputation model met this criterion (30, 58, 59 ): age at diagnosis, year of diagnosis, race/ethnicity, cancer registry, tumor characteristics (size, stage, grade, and histology), ER status, vital status, Jim Crow birthplace, and census tract socioeconomic index. As shown in Table 1 , there was no missing data for race/ethnicity, age at or year of diagnosis, or vital status; missingness for census tract socioeconomic index equaled 1.2%, and it was 12.3% for ER status and 49.4% for Jim Crow birthplace. To impute ER status (as ER-positive (ER+) vs. ER−), we grouped the small percentage of cases classified as borderline (0.4%) with those classified as unknown. We conducted sensitivity analyses using logical bounds (36) and employed two extreme scenarios: 1) all missing values assigned to Jim Crow birthplace for the black women and to non-Jim Crow birthplace for the white women, and 2) vice versa.
We first grouped the cases, stratified by race/ethnicity, into 5-year birth cohorts, and additionally stratified by age at diagnosis into 3 groups (<45 years (i.e., pre-menopausal), 45-54 years (perimenopausal), and 55 years or older (postmenopausal)), given the strong positive association between breast cancer ER+ status and age and the inverse association between age and the magnitude of the black versus white excess risk of ER− breast cancer (30) (31) (32) . We then computed the percentage of ER+ tumors for each group, equal to the average percentage ER+ across the 10 imputed data sets, and employed logistic regression to evaluate the odds ratio and 95% confidence interval for linear trend across birth cohorts.
For the haldane analyses, we set the reference birth cohort to be women born in 1945-1949, because it was the one birth cohort common to all 3 age groups (age at diagnosis: <45 years, 45-54 years, and 55 years or older) across the study time period. We re-expressed, as number of generations elapsed, the time difference between the reference birth cohort and each comparison birth cohort.
To calculate the change by biological generation in the proportion of cases that were ER+ versus ER− we used the formula: g The SEER census tract socioeconomic index is the first factor yielded by a factor analysis of measures of income, poverty, unemployment, occupational class, education, and house value (51, 52) where h = haldane, p 1 = proportion of cases in the reference birth cohort with the trait at time t 1 (when diagnosed with breast cancer), p 2 = proportion of cases in the comparison birth cohort with the trait at time t 2 (when diagnosed with breast cancer), and g = number of generations elapsed between t 1 and t 2 . This formula is a modification of the conventional haldane formula, which was developed for continuous traits (e.g., bone length) (10-13) and which calculates the difference, per pooled standard deviation, in the value of a trait at time t 1 versus t 2 , divided by the number of generations (g) elapsed between these 2 time points. Paleontological and contemporary animal studies indicate that the haldane typically hovers around 0-0.1, with high values (indicating rapid change) defined as being >0.3 (12). We computed confidence intervals, based on log binomial regression, using the standard errors of the log risk ratio (ln(p 2 ) − ln(p 1 )) for each birth cohort relative to 1947, multiplied by g/(t 2 − t 1 ). For generation length, our primary analyses set g to equal 22 years (i.e., midpoint for 20-24 years), based on historical and contemporary data about the US average age at first pregnancy (62) (63) (64) (65) . In sensitivity analyses we set g to equal 17, 27, and 32 years; because results were similar to those obtained for g = 22 years (see Web Tables 1-4 , available at https://academic.oup. com/aje), we report only our primary analyses. Table 1 presents data on the study population: US-born nonHispanic women (46,417 black and 339,830 white) diagnosed with primary invasive breast cancer between 1992 and 2012, who were aged 25-84 years (inclusive) at diagnosis, born between 1915-1979, and included in the SEER 13 Registry Group. Fully 92.2% of the black women and 95.8% of the white women were born before 1965 (the point when Jim Crow laws were abolished), and 45.7% and 57.9%, respectively, were aged 20 years or older in 1965. Across all years, the percentages of black and white women, respectively, born in a Jim Crow state equaled 43.6% and 20.3%, and the percentages diagnosed with ER+ tumors equaled 60.9% and 80.4%. Figure 1 presents graphs, stratified by race/ethnicity and age, that simultaneously plot according to birth cohort the point estimates and 95% confidence intervals for: 1) the proportion of ER+ tumors, and 2) the haldane value (high values are indicated by the line at 0.3). The point estimates for these graphs (based on g = 22 years) and for the corresponding sensitivity analyses (g = 17, 27, and 32 years) are provided in Web Tables 1-4. Two patterns stand out. First, among both black and white women, the ER+ proportion increased over time only among women younger than age 55 years at diagnosis. Among the black women younger than age 45 years at diagnosis, the ER+ proportion rose from 43 Elevated haldane values (>|0.2|, with 95% CI excluding 0) occurred only among the black women diagnosed before age 55 years, and high haldane values (>|0.3|, with 95% CI excluding 0) occurred only among black women diagnosed between ages 45-54 years and born after 1950. By contrast, the value of the haldane consistently hovered around 0 for both black and white women diagnosed at age 55 years or older and also among white women diagnosed under age 45 years. Tables 1-4) . Results were robust to the extreme scenarios employed in our sensitivity analyses (see Web Tables 5  and 6 ).
RESULTS
DISCUSSION
Our descriptive study provides novel data on the pace of change, according to biological generation, of breast cancer ER status at diagnosis among contemporary US-born black and white women. Key findings were that the percentage of ER+ cases rose, according to birth cohort (1915-1919 to 1975-1979) , only among the women diagnosed before age 55 years; that the changes according to biological generation were greater for the black women than for white women; and that among the black women, they were greatest for those born in the states with Jim Crow laws (versus non-Jim Crow states), with this group the only one to exhibit high haldane values (>|0.3|). The net impact, among women under age 55 years, was to close the ER+ prevalence gap between black and white women by half. Such rapid phenotypic change can plausibly be driven only by factors exogenous to populations' genomes (10) (11) (12) (13) (14) (15) (16) (17) (18) , despite emphasis in the literature on genetic contributions to black versus white risk of ER− breast tumors (31) (32) (33) (34) . By contrast, among women age 55 years or older at diagnosis, no trend was evident among the black women, whereas the white women exhibited a slight decline in ER+ proportion over time.
Interpretation of these results requires considering study strengths and limitations. First, we employed high-quality, NCI population-based, US cancer registry data, thus including all cases, regardless of access to care (66) . Although the SEER 13 Registry Group, which in 2010 contained 13.4% of the US population (50), is not fully representative of the US population, its registry locations nevertheless were chosen to be inclusive of diverse US geographic regions and major racial/ethnic groups (66) . Multiple imputation employed credible imputation models (30, 36, 58, 59) , as underscored by our sensitivity analyses. Studies comparing self-reported race/ethnicity and cancer registry data, moreover, have found high congruence for black and white patients, suggesting that racial/ethnic misclassification was low (67) .
Our results would also not be biased by US immigration policy (e.g., the restrictive Immigration Act of 1917 and Immigration Act of 1924 or the Immigrant and Nationality Act of 1965, which expanded immigration) (68, 69) , because all cases were US-born. We nevertheless lacked data on internal migration between year of birth and year of diagnosis; even without data on cumulative exposure, however, we could detect an impact of Jim Crow birthplace. We additionally lacked data on access to mammography. However, declining disparities between black and white women with respect to mammography screening rates (33, 70, 71) are unlikely to explain our results, because women younger than 45 years are not targeted for such screening, and we observed no rise in the ER+ proportion among the black women age 55 years or older. Our observational results are thus likely sufficiently sound to test our hypotheses about the pace of change, a necessary step before conducting studies to test etiological hypotheses about possible social and biological variables driving any observed trends.
Consonant with our findings, the few studies on trends in the ER status of breast cancer cases provide evidence of a significant rise in ER+ proportion over time. An investigation of 11,195 US tumor specimens spanning the period of 1973-1992 found that the percentage of ER+ cases rose from 73% to 78%; unable to explain this finding by "technical improvements or changes in tumor size, age, or nodal status," the authors inferred that "rising level of ER may reflect a change in breast cancer biology and in hormonal events that influence breast cancer genesis and growth" (72, p. 1601). A hospitalbased study of 900 archival breast tumor specimens in Glasgow (United Kingdom) observed that, between 1984-1986 and 1996-1997, the proportion of ER+ cases likewise rose from 64.2% to 71.5% (73) . A study of 1,290 archival specimens from the 1940s-1990s in Leeds (United Kingdom) attributed the finding that "[s]ignificantly more ER+ tumors were detected in the 1970s and 1990s cohorts compared with the 1940s cohort" to patients from the 1940s having "lived through two periods of food rationing during the First and Second World Wars" (74, pp. 272-273), given evidence that caloric restriction can affect breast cancer risk and subtype (74) . A new analysis of 16,494 Chinese women diagnosed with invasive breast cancer between 1994 and 2014 in the Shanghai Cancer Center found that exposure to the Great Famine of 1959-1961 increased the risk of having an ER− tumor, especially among women diagnosed before age 50 years and who experienced the famine before menarche, leading the authors to hypothesize that "famine, malnutrition, or the associated lack of fruit and vegetable consumption in adulthood may be related to epidemiological heterogeneity within breast cancer subtypes" (40, p. 361).
The handful of studies on Jim Crow laws and population health also support our findings. In this research, the strongest effects of Jim Crow abolition were observed among the US black population in Jim Crow states for decreased risk of infant mortality (23) (24) (25) (26) , premature mortality (27, 28) , and ER− breast cancer (especially among black women born before 1965) (36) . Likely explanations involve the myriad harms imposed by systemic, legal racial discrimination and extrajudicial violence, above and beyond forms of racial discrimination in non-Jim Crow states (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (75) (76) (77) .
Additional evidence regarding greater change in traits according to biological generation among the US-born black versus white population comes from our haldane analyses of long-term changes in anthropometric traits and age at menarche, using nationally representative data from the National Health Examination Survey (1959) (1960) (1961) (1962) and subsequent National Health and Nutrition Examination Studies (through 1999-2008) (15, 16, 18) . For example, height (a trait positively associated with risk of breast cancer, and specifically hormone receptor-positive breast cancer (42)) exhibited high rates of phenotypic change (haldane > 0.3) chiefly between 1960 and 1980, especially for the black population in the highest income quintile (15) . Additionally, for age at menarche (for which lower age is positively associated with risk of ER+ breast cancer (43)), haldane values of >0.3 were found solely among black women (all socioeconomic strata) and low-income white women who underwent menarche before 1960 (16) .
Together, these strands of evidence suggest that historical changes in socially determined early-life exposures affecting nutrition, age at menarche, and height may contribute to our study findings. Supporting this hypothesis are: 1) the persistent high and excess rates of being below the US poverty line among US black children compared with white childrennotably shifting from an excess of 65.6% versus 14.4% in 1965 to 32.9% versus 12.1% in 2015 (Web Table 7 Tables 8 and 9 ) (79-81). Although we lacked data to explore heterogeneity in state effects, the observed Jim Crow effect was robust to inclusion of census tract socioeconomic data (Web Tables 1-6 ), and other research has shown that current spatial patterns of racialized impoverishment in Jim Crow states are associated with earlier spatial distributions of enslavement and greater severity of Jim Crow regimes (20) (21) (22) 82) .
Other socially patterned and temporally changing exposures have been associated with tumor phenotype at diagnosis (44, 45) . For example, limited or no breastfeeding among parous women has been associated with increased risk of ER− breast tumors (43, (46) (47) (48) . However, this association would be unlikely to explain our findings, because a black/white reversal in breastfeeding occurred in the United States in the mid-1960s, shifting from a higher to lower prevalence and duration among US black versus white women (83, 84) . By contrast, the slight decline in ER+ tumors among white women diagnosed at age 55 years or older may in turn reflect their reduced use of hormone therapy following publication of the Women's Health Initiative results (38, 39) .
Taken together, our novel findings open up new questions relevant to understanding changing determinants of, and health inequities in, breast cancer ER status. Empirical research linking high-quality early-life exposure data to subsequent adult cancer remains scant, including for breast cancer; the limited extant evidence, however, implicates early-life exposures (in utero and once born) to nutrition and carcinogens, as shaped by early-life socioeconomic position (41, 85, 86) . Methods for augmenting cancer registry and vital statistics data on exposures by linking to online data capturing lifetime residential histories are likewise in their early stages, and they utilize data sources (such as credit-card transactions) for which electronic records typically extend only to the 1990s (87) (88) (89) . Our study underscores the need for improved methods and data to pursue historically informed analyses of how societal context, past and present, shapes contemporary risk of breast cancer ER status and social disparities in their distribution.
